Drug delivery device

• US 3,964,482 A
• Filed: 05/17/1971
• Issued: 06/22/1976
• Est. Priority Date: 05/17/1971
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Place, Virgil A., Gerstel, Martin S.
• Primary Examiner(s): Medbery, Aldrich F.
• Application Number:
  US05/144,061
• Time in Patent Office: 1,863 Days
• Field of Search: 128/260, 128/268, 128/215, 128/216, 128/253, 128/213, 128/2 W, 128/2 R, 128/1 R, 128/329, 128/330, 128/333, 128/314, 128/315
• US Class Current: 604/890.1
• CPC Class Codes: A61K 9/0021 Intradermal administration, e.g. through microneedle arrays, needleless injectors mechanical aspects A61M
• CPC Class Codes: A61M 2037/0023 Drug applicators using microneedles
• CPC Class Codes: A61M 37/0015 by using microneedles

Abstract

A drug delivery device for percutaneously administering a drug comprising a plurality of projections, a drug reservoir containing a drug, and where the projections extend from the reservoir and are adapted for penetrating the stratum corneum for percutaneously administering a drug from the reservoir to produce a local or systemic physiological or pharmacological effect.

Claims

1. A drug delivery device for percutaneously administering a drug comprising,

a. a plurality of puncturing projections, formed of a drug release rate controlling material permeable to passage of a drug by diffusion, and

b. a reservoir communicating with said projections containing the drug and whereby drug from the reservoir enters the projections and by diffusion through the projections is percutaneously administered through the stratum corneum of the epidermis.